Monocyte and macrophage contributions to cardiac remodeling

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 149-155

  Hulsmans, Maarten ^a   Sam, Flora ^b   Nahrendorf, Matthias ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac remodeling; Fibrosis; Hemodynamic stress; Macrophages; Monocytes; Myocardial infarction

Indexed keywords

ANGIOTENSIN II; CYTOKINE; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER;

CARDIAC REMODELING; CELL EXPANSION; CELL INTERACTION; CELL POPULATION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; HEART STRESS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; ANIMAL; CARDIAC MUSCLE; CELL COMMUNICATION; CELL PROLIFERATION; FIBROSIS; HEART VENTRICLE REMODELING; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE; TRANSLATIONAL RESEARCH;

ANIMALS; BIOMARKERS; CELL COMMUNICATION; CELL PROLIFERATION; FIBROSIS; HUMANS; MACROPHAGES; MONOCYTES; MYOCARDIUM; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH; VENTRICULAR REMODELING;

EID: 84947745483     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.015     Document Type: Review

References (94)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
2. Patten R.D., Hall-Porter M.R. Small animal models of heart failure: development of novel therapies, past and present. Circ. Heart Fail. 2009, 2:138-144.
3. Brilla C.G., Weber K.T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 1992, 120:893-901.
4. Tanaka K., Wilson R.M., Essick E.E., Duffen J.L., Scherer P.E., Ouchi N., et al. Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction. Circ. Heart Fail. 2014, 7:976-985.
5. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
6. Maekawa Y., Anzai T., Yoshikawa T., Asakura Y., Takahashi T., Ishikawa S., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J. Am. Coll. Cardiol. 2002, 39:241-246.
7. Barisione C., Garibaldi S., Ghigliotti G., Fabbi P., Altieri P., Casale M.C., et al. CD14CD16 monocyte subset levels in heart failure patients. Dis. Markers 2010, 28:115-124.
8. Wrigley B.J., Lip G.Y., Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur. J. Heart Fail. 2011, 13:1161-1171.
9. Wrigley B.J., Shantsila E., Tapp L.D., Lip G.Y. Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure. Thromb. Haemost. 2013, 110:92-100.
10. Shantsila E., Tapp L.D., Wrigley B.J., Pamukcu B., Apostolakis S., Montoro-García S., et al. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis. Atherosclerosis 2014, 234:4-10.
11. Glezeva N., Voon V., Watson C., Horgan S., McDonald K., Ledwidge M., et al. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. J. Card. Fail. 2015, 21:167-177.
12. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
13. Sunderkötter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004, 172:4410-4417.
14. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
15. Hettinger J., Richards D.M., Hansson J., Barra M.M., Joschko A.C., Krijgsveld J., et al. Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 2013, 14:821-830.
16. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
17. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 2011, 12:778-785.
18. Robbins C.S., Chudnovskiy A., Rauch P.J., Figueiredo J.L., Iwamoto Y., Gorbatov R., et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012, 125:364-374.
19. Leuschner F., Rauch P.J., Ueno T., Gorbatov R., Marinelli B., Lee W.W., et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 2012, 209:123-137.
20. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
21. Pinto A.R., Paolicelli R., Salimova E., Gospocic J., Slonimsky E., Bilbao-Cortes D., et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One 2012, 7.
22. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037-3047.
23. Heidt T., Courties G., Dutta P., Sager H.B., Sebas M., Iwamoto Y., et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ. Res. 2014, 115:284-295.
24. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
25. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
26. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
27. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
28. Zigmond E., Varol C., Farache J., Elmaliah E., Satpathy A.T., Friedlander G., et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090.
29. Tamoutounour S., Guilliams M., Montanana Sanchis F., Liu H., Terhorst D., Malosse C., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013, 39:925-938.
30. Epelman S., Lavine K.J., Beaudin A.E., Sojka D.K., Carrero J.A., Calderon B., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40:91-104.
31. Molawi K., Wolf Y., Kandalla P.K., Favret J., Hagemeyer N., Frenzel K., et al. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 2014, 211:2151-2158.
32. Hilgendorf I., Gerhardt L.M., Tan T.C., Winter C., Holderried T.A., Chousterman B.G., et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ. Res. 2014, 114:1611-1622.
33. Jakubzick C., Gautier E.L., Gibbings S.L., Sojka D.K., Schlitzer A., Johnson T.E., et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013, 39:599-610.
34. Frangogiannis N.G., Dewald O., Xia Y., Ren G., Haudek S., Leucker T., et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 2007, 115:584-592.
35. Dewald O., Zymek P., Winkelmann K., Koerting A., Ren G., Abou-Khamis T., et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 2005, 96:881-889.
36. Xia Y., Lee K., Li N., Corbett D., Mendoza L., Frangogiannis N.G. Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem. Cell Biol. 2009, 131:471-481.
37. Nicoletti A., Heudes D., Mandet C., Hinglais N., Bariety J., Michel J.B. Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc. Res. 1996, 32:1096-1107.
38. Swirski F.K., Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013, 339:161-166.
39. Kong P., Christia P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 2014, 71:549-574.
40. Mezzaroma E., Toldo S., Farkas D., Seropian I.M., Van Tassell B.W., Salloum F.N., et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19725-19730.
41. Bracey N.A., Gershkovich B., Chun J., Vilaysane A., Meijndert H.C., Wright J.R., et al. Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J. Biol. Chem. 2014, 289:19571-19584.
42. Bracey N.A., Beck P.L., Muruve D.A., Hirota S.A., Guo J., Jabagi H., et al. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β. Exp. Physiol. 2013, 98:462-472.
43. Ishibashi M., Hiasa K., Zhao Q., Inoue S., Ohtani K., Kitamoto S., et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ. Res. 2004, 94:1203-1210.
44. Kuwahara F., Kai H., Tokuda K., Takeya M., Takeshita A., Egashira K., et al. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation. Hypertension 2004, 43:739-745.
45. Kuwahara F., Kai H., Tokuda K., Niiyama H., Tahara N., Kusaba K., et al. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling. Hypertension 2003, 41:819-823.
46. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998, 101:890-898.
47. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
48. Wan E., Yeap X.Y., Dehn S., Terry R., Novak M., Zhang S., et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ. Res. 2013, 113:1004-1012.
49. Xue J., Schmidt S.V., Sander J., Draffehn A., Krebs W., Quester I., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014, 40:274-288.
50. Courties G., Heidt T., Sebas M., Iwamoto Y., Jeon D., Truelove J., et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J. Am. Coll. Cardiol. 2014, 63:1556-1566.
51. Usher M.G., Duan S.Z., Ivaschenko C.Y., Frieler R.A., Berger S., Schütz G., et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. Clin. Invest. 2010, 120:3350-3364.
52. Hu Y., Zhang H., Lu Y., Bai H., Xu Y., Zhu X., et al. Class a scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res. Cardiol. 2011, 106:1311-1328.
53. Ikeda J., Ichiki T., Matsuura H., Inoue E., Kishimoto J., Watanabe A., et al. Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling. J. Am. Heart Assoc. 2013, 2.
54. Yang M., Zheng J., Miao Y., Wang Y., Cui W., Guo J., et al. Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1675-1686.
55. Li Y., Zhang C., Wu Y., Han Y., Cui W., Jia L., et al. Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-induced cardiac fibrosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1662-1674.
56. Thum T. miRNA modulation of cardiac fibroblast phenotype. J. Mol. Cell. Cardiol. 2015, (in press).
57. Heymans S., Corsten M.F., Verhesen W., Carai P., van Leeuwen R.E., Custers K., et al. Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 2013, 128:1420-1432.
58. Kanellakis P., Ditiatkovski M., Kostolias G., Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc. Res. 2012, 95:77-85.
59. Small E., Lighthouse J.K. Transcriptional control of cardiac fibroblast plasticity. J. Mol. Cell. Cardiol. 2015, (in press, JMCC9591).
60. Hermans K.C., Daskalopoulos E.P., Blankesteijn W.M. The Janus face of myofibroblasts in the remodeling heart. J. Mol. Cell. Cardiol. 2015, (in press, JMCC9597).
61. Papageorgiou A.P., Rienks M. Novel regulators of cardiac inflammation: matricellular proteins expand their repertoire. J. Mol. Cell. Cardiol. 2015, (in press, JMCC9609).
62. Frangogiannis N.G., Mendoza L.H., Ren G., Akrivakis S., Jackson P.L., Michael L.H., et al. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H483-H492.
63. Frangogiannis N.G., Shimoni S., Chang S.M., Ren G., Shan K., Aggeli C., et al. Evidence for an active inflammatory process in the hibernating human myocardium. Am. J. Pathol. 2002, 160:1425-1433.
64. Ren J., Yang M., Qi G., Zheng J., Jia L., Cheng J., et al. Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by angiotensin II infusion. Am. J. Hypertens. 2011, 24:701-707.
65. Kagitani S., Ueno H., Hirade S., Takahashi T., Takata M., Inoue H. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J. Hypertens. 2004, 22:1007-1015.
66. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
67. Haudek S.B., Cheng J., Du J., Wang Y., Hermosillo-Rodriguez J., Trial J., et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2010, 49:499-507.
68. Pinto A.R., Godwin J.W., Chandran A., Hersey L., Ilinykh A., Debuque R., et al. Age-related changes in tissue macrophages precede cardiac functional impairment. Aging (Albany NY) 2014, 6:399-413.
69. Westermann D., Lindner D., Kasner M., Zietsch C., Savvatis K., Escher F., et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ. Heart Fail. 2011, 4:44-52.
70. Fallowfield J.A., Mizuno M., Kendall T.J., Constandinou C.M., Benyon R.C., Duffield J.S., et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 2007, 178:5288-5295.
71. Frangogiannis N.G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 2012, 110:159-173.
72. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013, 10:15-26.
73. Cortez-Retamozo V., Etzrodt M., Newton A., Ryan R., Pucci F., Sio S.W., et al. Angiotensin II drives the production of tumor-promoting macrophages. Immunity 2013, 38:296-308.
74. Rickard A.J., Morgan J., Tesch G., Funder J.W., Fuller P.J., Young M.J. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009, 54:537-543.
75. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
76. Lee S., Vinegoni C., Feruglio P.F., Fexon L., Gorbatov R., Pivoravov M., et al. Real-time in vivo imaging of the beating mouse heart at microscopic resolution. Nat. Commun. 2012, 3:1054.
77. Jung K., Kim P., Leuschner F., Gorbatov R., Kim J.K., Ueno T., et al. Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ. Res. 2013, 112:891-899.
78. Weissleder R., Nahrendorf M., Pittet M.J. Imaging macrophages with nanoparticles. Nat. Mater. 2014, 13:125-138.
79. Sosnovik D.E., Nahrendorf M., Deliolanis N., Novikov M., Aikawa E., Josephson L., et al. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 2007, 115:1384-1391.
80. Lee W.W., Marinelli B., van der Laan A.M., Sena B.F., Gorbatov R., Leuschner F., et al. PET/MRI of inflammation in myocardial infarction. J. Am. Coll. Cardiol. 2012, 59:153-163.
81. Nahrendorf M., Sosnovik D.E., Waterman P., Swirski F.K., Pande A.N., Aikawa E., et al. Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ. Res. 2007, 100:1218-1225.
82. Majmudar M.D., Keliher E.J., Heidt T., Leuschner F., Truelove J., Sena B.F., et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 2013, 127:2038-2046.
83. van Rooijen N., Hendrikx E. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol. Biol. 2010, 605:189-203.
84. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
85. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 2013, 16:273-280.
86. Gomez Perdiguero E., Klapproth K., Schulz C., Busch K., Azzoni E., Crozet L., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015, 518:547-551.
87. Sheng J., Ruedl C., Karjalainen K. Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity 2015, 43:382-393.
88. Dunay I.R., Damatta R.A., Fux B., Presti R., Greco S., Colonna M., et al. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008, 29:306-317.
89. Kim Y.G., Kamada N., Shaw M.H., Warner N., Chen G.Y., Franchi L., et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 2011, 34:769-780.
90. Mulder W.J., Jaffer F.A., Fayad Z.A., Nahrendorf M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci. Transl. Med. 2014, 6.
91. Harel-Adar T., Ben Mordechai T., Amsalem Y., Feinberg M.S., Leor J., Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1827-1832.
92. de Couto G., Liu W., Tseliou E., Sun B., Makkar N., Kanazawa H., et al. Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J. Clin. Invest. 2015, 125:3147-3162.
93. Wang Y., Yang T., Ma Y., Halade G.V., Zhang J., Lindsey M.L., et al. Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling post-myocardial infarction. BMC Genomics 2012, 13(Suppl. 6):S21.
94. Jin Y.F., Han H.C., Berger J., Dai Q., Lindsey M.L. Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling. BMC Syst. Biol. 2011, 5:60.